Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Prana Biotechnology Ltd

+ Add to Watchlist

PRAN:US

1.1100 USD 0.0599 5.12%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Prana Biotechnology Ltd (PRAN)

Open: 1.2100 Day's Range: 1.1100 - 1.2100 Volume: 733,703
Previous Close: 1.1699 52wk Range: 1.0700 - 11.5900 1-Yr Rtn: -90.19%

Stock Chart for PRAN

No chart data available.
  • PRAN:US 1.1100
  • 1D
  • 1M
  • 1Y
1.1699
Interactive PRAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRAN

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -
Est. PEG Ratio -
Market Cap (M USD) 58.51
Shares Outstanding (M) 52.71
30 Day Average Volume 524,420
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRAN

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PRAN

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Geoffrey P KemplerChairman/CEO/Co-FounderRichard RevelinsCFO/Secretary
Phillip HainsActing CFODiane AngusChief Operating Officer
More Company Profile & Key Executives for PRAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil